Brief: Regenxbio Announces Expansion Of Affinity Duchenne Trial
24/06/2024 12:15
June 24 (Reuters) - Regenxbio Inc RGNX.O :
* REGENXBIO ANNOUNCES EXPANSION OF AFFINITY DUCHENNE® TRIAL
TO
INCLUDE A NEW COHORT OF YOUNGER PATIENTS
* REGENXBIO INC: ON TRACK TO INITIATE PIVOTAL TRIAL IN LATE
Q3 TO
EARLY Q4 2024
Source text for Eikon: ID:nPn1N1BSfa
Further company coverage: RGNX.O
((Reuters.Briefs@thomsonreuters.com;))